
### [MONDO:0016195](http://purl.obolibrary.org/obo/MONDO_0016195)
**Label:** qualitative or quantitative defects of beta-myosin heavy chain (MYH7)

**Subclasses:** [MONDO:0018889](http://purl.obolibrary.org/obo/MONDO_0018889) (hyaline body myopathy), 

**Corr. equiv. classes:** [Orphanet:53698](http://www.orpha.net/ORDO/Orphanet_53698), [OMIM:255160](http://purl.obolibrary.org/obo/OMIM_255160), [OMIM:608358](http://purl.obolibrary.org/obo/OMIM_608358), 

**Class expressions from DL-Learner:**

- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 66.67%
- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 66.67%
- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 66.67%
- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 66.67%
- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) 66.67%
- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0009055](http://purl.obolibrary.org/obo/HP_0009055) (Generalized limb muscle atrophy) 66.67%
- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) 66.67%
- [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) and [HP:0003803](http://purl.obolibrary.org/obo/HP_0003803) (Type 1 muscle fiber predominance) 66.67%
- [HP:0003704](http://purl.obolibrary.org/obo/HP_0003704) (Scapuloperoneal weakness) and [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) 66.67%
- [HP:0003700](http://purl.obolibrary.org/obo/HP_0003700) (Generalized amyotrophy) and [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) 66.67%
- [HP:0003697](http://purl.obolibrary.org/obo/HP_0003697) (Scapuloperoneal amyotrophy) and [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) 66.67%
- [HP:0003691](http://purl.obolibrary.org/obo/HP_0003691) (Scapular winging) and [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) 66.67%
- [HP:0003687](http://purl.obolibrary.org/obo/HP_0003687) (Centrally nucleated skeletal muscle fibers) and [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) 66.67%
- [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) 66.67%
- [HP:0003677](http://purl.obolibrary.org/obo/HP_0003677) (Slow progression) and [HP:0003707](http://purl.obolibrary.org/obo/HP_0003707) (Calf muscle pseudohypertrophy) 66.67%


